Validation of Ultrasound "Angle of Progression" Measurement to Decrease the Cesarean Rate
Launched by HOSPITAL ST. JOSEPH, MARSEILLE, FRANCE · Mar 9, 2023
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help reduce the number of cesarean deliveries during labor. Researchers are looking at a technique called "Angle of Progression" using ultrasound to see how well the baby's head is moving down the birth canal. They believe that measuring this angle can provide valuable information, especially after a prolonged second stage of labor, which is when a woman has been pushing for an extended period. The goal is to see if using this ultrasound measurement, alongside traditional checks, can lower the cesarean rate significantly.
To participate, women must be at least 37 weeks pregnant, either having their first baby or having had previous pregnancies without vaginal deliveries. They need to have their baby in the head-down position, but there should be some uncertainty about whether the baby's head is engaged in the birth canal after pushing for at least two hours. If eligible, participants can expect to be part of a randomized trial, which means they may be placed in either the ultrasound measurement group or the standard care group. This research could play an important role in understanding how to help more women have vaginal births safely.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Nulliparous or multiparous women with no history of vaginal delivery,
- • \> or = 37 weeks amenorrhoea
- • Cephalic presentation in anterior position (occipito-pubic position, left anterior occipito-iliac and right anterior occipito-iliac ) confirmed by ultrasound
- • uncertain fetal head engagement on digital examination or midline fetal presentation in prolonged second stage of labor (at least 2 hours),
- Exclusion Criteria:
- • Multiparous women who were previous vaginal deliveries,
- • Presentation other than cephalic,
- • Twin pregnancies,
- • Posterior or transverse position
- • Transperineal ultrasound for head-perineum distance measurement
- • Fetal heart rate abnormalities requiring rapid delivery,
- • Contraindication to vaginal delivery whether maternal or fetal
About Hospital St. Joseph, Marseille, France
Hospital St. Joseph, located in Marseille, France, is a leading healthcare institution dedicated to providing high-quality patient care and advancing medical research. With a commitment to innovation and excellence, the hospital serves as a pivotal clinical trial sponsor, facilitating cutting-edge studies that aim to enhance treatment options and improve patient outcomes. Its multidisciplinary approach leverages a team of experienced healthcare professionals and researchers, ensuring a collaborative environment that fosters scientific inquiry and the translation of research findings into clinical practice. Additionally, Hospital St. Joseph prioritizes patient safety and ethical standards, making it a trusted partner in the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Marseille, , France
Marseille, , France
Paris, , France
Lille, , France
Marseille, , France
Poissy, , France
Toulon, , France
Patients applied
Trial Officials
Jean-Baptiste Haumonte
Principal Investigator
Hopital Saint Joseph Marseille
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials